Data Science in the News

Did you know we have a monthly newsletter? View past volumes and subscribe.

Unprecedented multiscale model of protein behavior linked to cancer-causing mutations

Jan. 10, 2022 - 
LLNL researchers and a multi-institutional team have developed a highly detailed, machine learning–backed multiscale model revealing the importance of lipids to the signaling dynamics of RAS, a family of proteins whose mutations are linked to numerous cancers. Published by the Proceedings of the National Academy of Sciences, the paper details the methodology behind the Multiscale Machine...

LLNL establishes AI Innovation Incubator to advance artificial intelligence for applied science

Dec. 20, 2021 - 
LLNL has established the AI Innovation Incubator (AI3), a collaborative hub aimed at uniting experts in artificial intelligence (AI) from LLNL, industry and academia to advance AI for large-scale scientific and commercial applications. LLNL has entered into a new memoranda of understanding with Google, IBM and NVIDIA, with plans to use the incubator to facilitate discussions and form future...

Digital twins for cancer patients could be ‘paradigm shift’ for predictive oncology

Dec. 16, 2021 - 
A multi-institutional team, including an LLNL contributor, has proposed a framework for digital twin models of cancer patients that researchers say would create a “paradigm shift” for predictive oncology. Published online Nature Medicine on November 25, the proposed framework for Cancer Patient Digital Twins (CPDTs) — virtual representations of cancer patients using real-time data — would...

LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

Oct. 21, 2021 - 
LLNL has joined the international Human Vaccines Project (HVP), bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response. The HVP is a nonprofit, public-private partnership with a mission to decode the human immune system and accelerate the development of vaccines and immunotherapies...

Tackling the COVID-19 pandemic

Oct. 11, 2021 - 
To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

Lab-led effort one of nine DOE-funded data reduction projects

Sept. 17, 2021 - 
An LLNL-led effort in data compression was one of nine projects recently funded by the DOE for research aimed at shrinking the amount of data needed to advance scientific discovery. Under the project—ComPRESS: Compression and Progressive Retrieval for Exascale Simulations and Sensors—LLNL scientists will seek better understanding of data-compression errors, develop models to increase trust in...

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

June 7, 2021 - 
LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

Advanced Data Analytics for Proliferation Detection shares technical advances during two-day meeting

May 7, 2021 - 
The Advanced Data Analytics for Proliferation Detection (ADAPD) program held a two-day virtual technical exchange meeting recently. The goal of the meeting was to highlight the science-based and data-driven analysis work conducted by ADAPD to advance the state-of-the-art to accelerate artificial intelligence (AI) innovation and develop AI-enabled systems to enhance the United States’...

Virtual seminar series explores data-driven physical simulations

April 6, 2021 - 
The rapidly growing fields of artificial intelligence (AI) and machine learning (ML) have become cornerstones of LLNL’s data science research activities. The Lab’s scientific community regularly publishes advancements in both AI/ML applications and theory, contributing to international discourse on the possibilities of these compelling technologies. The large volume of AI/ML scientific...

COVID-19 HPC Consortium reflects on past year

April 1, 2021 - 
COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

Lab researchers explore ‘learn-by-calibration’ approach to deep learning to accurately emulate scientific process

Feb. 10, 2021 - 
An LLNL team has developed a “Learn-by-Calibrating” method for creating powerful scientific emulators that could be used as proxies for far more computationally intensive simulators. Researchers found the approach results in high-quality predictive models that are closer to real-world data and better calibrated than previous state-of-the-art methods. The LbC approach is based on interval...

Model for COVID-19 drug discovery a Gordon Bell finalist

Nov. 17, 2020 - 
A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

Advancing healthcare with data science (VIDEO)

Aug. 3, 2020 - 
This video provides an overview of projects in which data scientists work with domain scientists to address major challenges in healthcare. To help fight the COVID-19 pandemic, researchers are developing computer models to search for potential antibody and antiviral drug treatments, sharing a data portal with scientists and the general public, and analyzing drug compounds via a novel text...

Lab team studies calibrated AI and deep learning models to more reliably diagnose and treat disease

May 29, 2020 - 
A team led by LLNL computer scientist Jay Thiagarajan has developed a new approach for improving the reliability of artificial intelligence and deep learning-based models used for critical applications, such as health care. Thiagarajan recently applied the method to study chest X-ray images of patients diagnosed with COVID-19, arising due to the novel SARS-Cov-2 coronavirus. Read more at LLNL...

COVID-19 research goes public through new portal

May 18, 2020 - 
A new online data portal is making available to the public a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based “virtual” screening of small molecules and designed antibodies for interactions with the SARS-CoV-2 virus for drug design purposes. The portal houses a wealth of data LLNL scientists have gathered from...

Interpretable AI in healthcare (PODCAST)

May 17, 2020 - 
LLNL's Jay Thiagarajan joins the Data Skeptic podcast to discuss his recent paper "Calibrating Healthcare AI: Towards Reliable and Interpretable Deep Predictive Models." The episode runs 35:50. Listen at Data Skeptic.

The incorporation of machine learning into scientific simulations at LLNL (VIDEO)

May 5, 2020 - 
In this video from the Stanford HPC Conference, Katie Lewis presents "The Incorporation of Machine Learning into Scientific Simulations at Lawrence Livermore National Laboratory." Read more and watch the video at insideHPC.

New ML platform generates novel COVID-19 antibody sequences for experimental testing

May 1, 2020 - 
LLNL researchers have identified an initial set of therapeutic antibody sequences, designed in a few weeks using machine learning and supercomputing, aimed at binding and neutralizing SARS-CoV-2, the virus that causes COVID-19. The research team is performing experimental testing on the chosen antibody designs. Read more at LLNL News.

Using data to build a secure future (PODCAST)

April 21, 2020 - 
On the Hidden in Plain Sight podcast, LLNL director Bill Goldstein explains how the Lab crunches data to shape the future. Listen at Mission.org.

Upgrades for LLNL supercomputer from AMD, Penguin Computing aid COVID-19 research

April 21, 2020 - 
Under a new agreement, AMD will supply upgraded graphics accelerators for LLNL’s Corona supercomputing cluster, expected to nearly double the system’s peak compute power. The system will be used by scientists through the public/private COVID-19 HPC Consortium, and by LLNL researchers, who are working on discovering potential antibodies and anti-viral compounds for SARS-CoV-2, the virus that...